3.35
Biomerica Inc stock is traded at $3.35, with a volume of 59,544.
It is down -8.97% in the last 24 hours and down -38.89% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$3.68
Open:
$3.61
24h Volume:
59,544
Relative Volume:
0.07
Market Cap:
$1.45M
Revenue:
$5.51M
Net Income/Loss:
$-6.16M
P/E Ratio:
-9.0541
EPS:
-0.37
Net Cash Flow:
$-5.03M
1W Performance:
-26.52%
1M Performance:
-38.89%
6M Performance:
+29.64%
1Y Performance:
-42.22%
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BMRA
Biomerica Inc
|
3.35 | 1.45M | 5.51M | -6.16M | -5.03M | -0.37 |
![]()
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-10-20 | Initiated | Colliers Securities | Buy |
Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Stock Set to Reverse Split on Monday, April 21st (NASDAQ:BMRA) - Defense World
Biomerica announces reverse stock split - Medical Buyer
Biomerica announces reverse stock split to meet Nasdaq requirements - Investing.com Australia
Biomerica announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
Biomerica Announced 1-for-8 Reverse Stock Split - Nasdaq
Biomerica Plans Reverse Stock Split to Regain Nasdaq Listing Compliance - MarketScreener
Biomerica Announces 1-for-8 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Benzinga
Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective April 2025 | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split Effective April 21 - TipRanks
Biomerica, Inc. Announces 1-for-8 Reverse Stock Split Effective April 21, 2025 - Nasdaq
Biomerica Announces Reverse Stock Split - TradingView
3 High-Value Companies With Triple-Digit Upside Potential - The Globe and Mail
Biomerica Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
Biomerica Reports Third Quarter Fiscal 2025 Financial Results | - GuruFocus
Biomerica (BMRA) Reports Q3 Revenue Increase and Lower Expenses - GuruFocus
Wheat Losses Continuing on Tuesday Morning - The Globe and Mail
Biomerica Turns Corner: 10% Growth, Cost Cuts, and Major Regulatory Wins Boost Q3 Results - Stock Titan
BIOMERICA INC SEC 10-Q Report - TradingView
La Mancha Investment buying more Belo Sun Mining (BSX) - The Globe and Mail
Biomerica (NASDAQ:BMRA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Biomerica (NASDAQ:BMRA) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Enteric Disease Testing Market Set to Witness Significant - openPR.com
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 65.5% in March - Defense World
Biomerica (NASDAQ:BMRA) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 64.6% - Defense World
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR - Yahoo
Biomerica gains EU certification for IBD food intolerance products By Investing.com - Investing.com South Africa
Biomerica gains EU certification for IBD food intolerance products - Investing.com India
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis - The Manila Times
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests ... - The Bakersfield Californian
Can Biomerica's Newly Certified IBD Tests Transform Crohn's and Colitis Management in Europe? - StockTitan
Biomerica (NASDAQ:BMRA) Stock Quotes, Forecast and News Summary - Benzinga
Biomerica reports Q2 EPS (6c) vs. (9c) last year - MSN
Biomerica'S Infoods® IBS Clinical Trial Results Published And Featured In Gastroenterology, The Leading Gi Medical Journal - Marketscreener.com
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):